Insider Trades21 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | Sell | SVRA | David L Lowrance | Chief Financial Officer | 1,160,374 | $3.69 | $1.1B | -24.34% | +58.68% | $4.3M | +0.00% | — | Sell Now |
| Mar 18, 2026 | Buy | SVRA | David L Lowrance | Chief Financial Officer | 483,507 | $2.43 | $1.1B | -24.34% | +58.68% | $1.2M | +4.12% | — | Sell Now |
| Dec 14, 2025 | Sell | SVRA | Kathleen R. Mccabe | Chief Legal Officer | 39,350 | $6.92 | $1.1B | -24.34% | +58.68% | $272.3K | -7.04% | — | Sell Now |
| Dec 14, 2025 | Sell | SVRA | Anne Erickson | Chief Business Officer | 62,960 | $6.92 | $1.1B | -24.34% | +58.68% | $435.7K | -14.48% | — | Sell Now |
| Dec 14, 2025 | Sell | SVRA | David L Lowrance | Chief Financial Officer | 94,960 | $4.59 | $1.1B | -24.34% | +58.68% | $435.7K | -13.58% | — | Sell Now |
| Dec 14, 2025 | Sell | SVRA | Robert Matthew Lutz | Chief Operating Officer | 67,760 | $6.92 | $1.1B | -24.34% | +58.68% | $468.9K | -18.73% | — | Sell Now |
| Dec 14, 2025 | Sell | SVRA | Matthew Pauls | CHIEF EXECUTIVE OFFICER | 324,700 | $4.17 | $1.1B | -24.34% | +58.68% | $1.4M | -11.47% | — | Sell Now |
| Dec 10, 2025 | Sell | SVRA | Matthew Pauls | CHIEF EXECUTIVE OFFICER | 23,629 | $6.69 | $1.1B | -24.34% | +58.68% | $158.1K | -1.54% | — | Sell Now |
| Dec 4, 2025 | Sell | SVRA | Yasmine Wasfi | Chief Medical Officer | 21,992 | $6.37 | $1.1B | -24.34% | +58.68% | $140.1K | -11.57% | — | Sell Now |
| Feb 13, 2025 | Sell | SVRA | Robert Matthew Lutz | Chief Operating Officer | 38,263 | $2.83 | $1.1B | -24.34% | +58.68% | $108.3K | -9.57% | — | Sell Now |
| Dec 13, 2024 | Sell | SVRA | Anne Erickson | Chief Business Officer | 18,263 | $3.21 | $1.1B | -24.34% | +58.68% | $58.6K | -2.43% | — | Sell Now |
| Dec 13, 2024 | Sell | SVRA | David L Lowrance | Chief Financial Officer | 61,350 | $2.63 | $1.1B | -24.34% | +58.68% | $161.4K | -3.89% | — | Sell Now |
| Dec 13, 2024 | Sell | SVRA | Matthew Pauls | CHIEF EXECUTIVE OFFICER | 147,295 | $3.25 | $1.1B | -24.34% | +58.68% | $478.1K | -3.53% | — | Sell Now |
| Nov 10, 2024 | Sell | SVRA | Raymond Dennis Pratt | Chief Medical Officer | 49,950 | $3.97 | $1.1B | -24.34% | +58.68% | $198.3K | -16.11% | — | Sell Now |
| Oct 21, 2024 | Sell | SVRA | Anne Erickson | Chief Business Officer | 381 | $3.57 | $1.1B | -24.34% | +58.68% | $1.4K | -0.11% | — | Sell Now |
| Jul 21, 2024 | Sell | SVRA | Anne Erickson | Chief Business Officer | 381 | $4.47 | $1.1B | -24.34% | +58.68% | $1.7K | -0.11% | — | Sell Now |
| Apr 21, 2024 | Sell | SVRA | Anne Erickson | Chief Business Officer | 381 | $4.81 | $1.1B | -24.34% | +58.68% | $1.8K | -0.11% | — | Sell Now |
| Dec 28, 2023 | Sell | SVRA | David L Lowrance | CHIEF FINANCIAL OFFICER | 10,000 | $4.71 | $1.1B | -24.34% | +58.68% | $47.1K | -2.84% | — | Sell Now |
| Dec 28, 2023 | Sell | SVRA | Matthew Pauls | CHIEF EXECUTIVE OFFICER | 103,000 | $3.84 | $1.1B | -24.34% | +58.68% | $395.9K | -3.83% | — | Sell Now |
| Dec 14, 2023 | Sell | SVRA | David L Lowrance | CHIEF FINANCIAL OFFICER | 50,438 | $2.69 | $1.1B | -24.34% | +58.68% | $135.4K | -7.70% | — | Sell Now |
| Dec 14, 2023 | Sell | SVRA | Matthew Pauls | CHIEF EXECUTIVE OFFICER | 109,680 | $4.45 | $1.1B | -24.34% | +58.68% | $488.1K | -8.63% | — | Sell Now |